RESOURCES

/

FIND A SPECIALIST

/

CONTACT

NephCure Specialist of the Month: Meet Dr. Frederick Kaskel

We are incredibly proud to highlight Dr. Frederick Kaskel, our NephCure Specialist of the Month for February. This initiative recognizes the outstanding contributions of NephCure Specialists in the field of nephrology, spotlighting their work, projects, accomplishments, and valuable advice to the rare kidney disease (RKD) patient community.

Dr. Frederick Kaskel, Chief Emeritus Pediatric Nephrology, Children’s Hospital at Montefiore, Albert Einstein College of Medicine, is a translational investigator with expertise in basic renal physiology and research in glomerular disease and chronic kidney failure in children.

Throughout his career, he has demonstrated successful experiences in leading national and international scientific activities, such as the Principal Investigator of one of the few NIH clinical trials funded by NIDDK on the treatment of Focal Segmental Glomerulosclerosis Clinical Trial, President of the 15th Scientific Congress of the International Pediatric Nephrology Association and former President of the American Society of Pediatric Nephrology.

Reflecting on his history with NephCure and its patient community, Dr. Kaskel shared, “As a pediatric nephrologist I have always considered it a privilege to have the fortunate opportunity to become part of a family’s personal interactions in the care of the patient.  The concept of ‘family-centered care’ encompasses everything that we should acknowledge in providing assistance and treatments for the family and their loved ones.  The NephCure patient community makes this goal achievable by providing a network for trusted interactions.”

Dr. Kaskel is currently optimistic about the impressive advancements in the early diagnosis and identifying the causes of rare kidney diseases, such as FSGS and IgA Nephropathy among others, that have resulted in clinical trials of targeted therapies. 

“The number of such trials has impressively increased over the past five years with promising long-term outcomes and preservation of kidney function.  These advances extend throughout the life course from early childhood to older age and hold the potential for eventual gene therapies for various congenital renal disorders.”

For more information about NephCure Specialists and to find rare kidney disease experts in your area, visit NephCure’s Find A Specialist webpage!

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.